- Home
- SES vs RGC Comparison
SES vs RGC Comparison
Compare SES & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SES
- RGC
- Stock Information
- Founded
- SES 2012
- RGC 2014
- Country
- SES United States
- RGC Hong Kong
- Employees
- SES N/A
- RGC N/A
- Industry
- SES Auto Parts:O.E.M.
- RGC Medicinal Chemicals and Botanical Products
- Sector
- SES Consumer Discretionary
- RGC Health Care
- Exchange
- SES Nasdaq
- RGC Nasdaq
- Market Cap
- SES 110.3M
- RGC 105.3M
- IPO Year
- SES N/A
- RGC 2021
- Fundamental
- Price
- SES $0.88
- RGC $5.00
- Analyst Decision
- SES Sell
- RGC
- Analyst Count
- SES 2
- RGC 0
- Target Price
- SES $1.25
- RGC N/A
- AVG Volume (30 Days)
- SES 42.4M
- RGC 6.6K
- Earning Date
- SES 02-24-2025
- RGC 10-25-2024
- Dividend Yield
- SES N/A
- RGC N/A
- EPS Growth
- SES N/A
- RGC N/A
- EPS
- SES N/A
- RGC N/A
- Revenue
- SES N/A
- RGC N/A
- Revenue This Year
- SES N/A
- RGC N/A
- Revenue Next Year
- SES N/A
- RGC N/A
- P/E Ratio
- SES N/A
- RGC N/A
- Revenue Growth
- SES N/A
- RGC N/A
- 52 Week Low
- SES $0.20
- RGC $3.03
- 52 Week High
- SES $2.53
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- SES 45.29
- RGC 48.07
- Support Level
- SES $0.76
- RGC $4.81
- Resistance Level
- SES $1.13
- RGC $4.95
- Average True Range (ATR)
- SES 0.32
- RGC 0.24
- MACD
- SES -0.13
- RGC 0.04
- Stochastic Oscillator
- SES 7.36
- RGC 56.88
About SES SES AI Corporation
SES AI Corp is a pre-commercialization stage company engaged in the development and initial production of high-performance Lithium-Metal (Li-Metal) rechargeable battery technologies for electric vehicles (EVs), urban air mobility (UAM), which encompasses electric vehicle take-off and landing (eVTOL), and other applications. The company is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms, and recycling.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.